| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACHC | Common Stock, par value $0.01 per share | Sale | -$1.83M | -27.5K | -4.9% | $66.47 | 534K | Jun 14, 2021 | See Footnotes | F1, F2, F3, F4, F5 |
| transaction | ACHC | Common Stock, par value $0.01 per share | Sale | -$1.83M | -27.5K | -5.15% | $66.47 | 507K | Jun 14, 2021 | See Footnotes | F3, F4, F5, F6, F7 |
| holding | ACHC | Common Stock, par value $0.01 per share | 28.3K | Jun 14, 2021 | Direct |
| Id | Content |
|---|---|
| F1 | Represents shares sold by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"). |
| F2 | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $66.27 to $66.89, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| F3 | The shares are owned of record as follows: (i) 157,491 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the 2012 RBW Jr Family Trust, and (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"). |
| F4 | Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries. |
| F5 | Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. |
| F6 | Represents shares sold by the 2012 CRMW Family Trust. |
| F7 | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $66.27 to $66.97, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |